World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
69
Citations
15724
World Ranking
2518
National Ranking
218

Paul M. Kaye publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Paul M. Kaye sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 227 publications — 44th percentile

44% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Paul M. Kaye D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Paul M. Kaye sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 69 D-Index — 50th percentile

50% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Paul M. Kaye is affiliated with Hull York Medical School in the United Kingdom. Their research primarily focuses on medicine, with significant contributions to immunology and microbiology. Within these fields, their work spans key subfields including public health, environmental and occupational health, epidemiology, immunology, infectious diseases, and parasitology.

The research topics covered by Paul M. Kaye include:

  • Research on Leishmaniasis Studies
  • Trypanosoma species research and implications
  • Parasites and Host Interactions
  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 and COVID-19 Research
  • Immune Cell Function and Interaction
  • Insect and Pesticide Research

Frequent co-authors collaborating with Paul M. Kaye comprise Helen Ashwin, Charles Lacey, Nidhi Sharma Dey, Alison Layton, and Dimitris Lagos.

Paul M. Kaye has published extensively in a range of venues, with frequent contributions to:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • PLoS Neglected Tropical Diseases
  • Wellcome Open Research
  • Zenodo (CERN European Organization for Nuclear Research)
  • Frontiers in Cellular and Infection Microbiology

Notable recent papers authored or co-authored by Paul M. Kaye include:

  • Leishmaniasis immunopathology-impact on design and use of vaccines, diagnostics and drugs (2020, Seminars in Immunopathology)
  • Malat1 Suppresses Immunity to Infection through Promoting Expression of Maf and IL-10 in Th Cells (2020, The Journal of Immunology)
  • Safety and immunogenicity of ChAd63-KH vaccine in post-kala-azar dermal leishmaniasis patients in Sudan (2021, Molecular Therapy)
  • Characterization of a new Leishmania major strain for use in a controlled human infection model (2021, Nature Communications)
  • Integrated miRNA/cytokine/chemokine profiling reveals severity-associated step changes and principal correlates of fatality in COVID-19 (2021, iScience)

Best Publications

  • Leishmaniasis: complexity at the host–pathogen interface

    Paul Kaye;Phillip Scott

  • Leishmaniasis: new approaches to disease control

    Clive R Davies;Paul Kaye;Simon L Croft;Shyam Sundar

  • The role of dendritic cells in the induction and regulation of immunity to microbial infection.

    Caetano Reis e Sousa;Alan Sher;Paul Kaye

  • DENDRITIC CELLS, BUT NOT MACROPHAGES, PRODUCE IL-12 IMMEDIATELY FOLLOWING LEISHMANIA DONOVANI INFECTION

    Patricia M. A. Gorak;Christian R. Engwerda;Paul M. Kaye

  • Locally Up-regulated Lymphotoxin α, Not Systemic Tumor Necrosis Factor α, Is the Principle Mediator of Murine Cerebral Malaria

    Christian R. Engwerda;Tracey L. Mynott;Sanjeet Sawhney;J. Brian De Souza

  • The immunopathology of experimental visceral leishmaniasis

    Paul M. Kaye;Mattias Svensson;Manabu Ato;Asher Maroof

  • Differential production of Th1- and Th2-derived cytokines does not determine the genetically controlled or vaccine-induced rate of cure in murine visceral leishmaniasis.

    P M Kaye;A J Curry;J M Blackwell

  • B Cell-Deficient Mice Are Highly Resistant to Leishmania donovani Infection, but Develop Neutrophil-Mediated Tissue Pathology

    Sara C. Smelt;Sara E. J. Cotterell;Christian R. Engwerda;Paul M. Kaye

  • Bone marrow-derived and resident liver macrophages display unique transcriptomic signatures but similar biological functions

    Lynette Beattie;Lynette Beattie;Amy Sawtell;Jason L. Mann;Teija C.M. Frame

  • Natural antibodies and complement are endogenous adjuvants for vaccine-induced CD8+ T-cell responses.

    Simona Stäger;James Alexander;Alun C Kirby;Marina Botto

  • Immunization with a Recombinant Stage-Regulated Surface Protein from Leishmania donovani Induces Protection Against Visceral Leishmaniasis

    Simona Stäger;Deborah F. Smith;Paul M. Kaye

  • Macrophages, pathology and parasite persistence in experimental visceral leishmaniasis

    Christian R. Engwerda;Manabu Ato;Paul M. Kaye

  • Stromal Cells Direct Local Differentiation of Regulatory Dendritic Cells

    Mattias Svensson;Asher Maroof;Manabu Ato;Paul M. Kaye

  • Defective CCR7 expression on dendritic cells contributes to the development of visceral leishmaniasis.

    Manabu Ato;Simona Stäger;Christian R. Engwerda;Paul M. Kaye

  • Alveolar macrophages transport pathogens to lung draining lymph nodes.

    Alun C. Kirby;Mark C. Coles;Paul M. Kaye

  • Organ-specific immune responses associated with infectious disease.

    Christian R Engwerda;Paul M Kaye

  • A randomised, double-blind, controlled vaccine efficacy trial of DNA/MVA ME-TRAP against malaria infection in Gambian adults.

    Vasee S Moorthy;Egeruan B Imoukhuede;Paul Milligan;Kalifa Bojang

  • Posttranscriptional Regulation of Il10 Gene Expression Allows Natural Killer Cells to Express Immunoregulatory Function

    Asher Maroof;Lynette Beattie;Soombul Zubairi;Mattias Svensson

  • Blockade of CTLA-4 enhances host resistance to the intracellular pathogen, Leishmania donovani.

    Michaela L. Murphy;Sara E. J. Cotterell;Patricia M. A. Gorak;Christian R. Engwerda

  • IL-7-producing stromal cells are critical for lymph node remodeling

    Lucas Onder;Priyanka Narang;Elke Scandella;Qian Chai

  • Infectious diseases of humans: Dynamics and control

    Paul M. Kaye

Frequent Co-Authors

Christian R. Engwerda
Christian R. Engwerda QIMR Berghofer Medical Research Institute
Deborah F. Smith
Deborah F. Smith University of York
Mark Coles
Mark Coles University of Oxford
Jon Timmis
Jon Timmis University of Sunderland
Simon L. Croft
Simon L. Croft London School of Hygiene & Tropical Medicine
James Alexander
James Alexander Centers for Disease Control and Prevention
Toni Aebischer
Toni Aebischer Robert Koch Institute
Mitali Chatterjee
Mitali Chatterjee Bose (United States)
Miles A. Whittington
Miles A. Whittington University of York
Jeremy C. Mottram
Jeremy C. Mottram University of York

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing related healthcare degrees can open diverse career opportunities. Accelerated nursing programs are a popular choice for individuals seeking a fast-track route into nursing, allowing students to quickly gain essential skills and begin clinical practice.

Many programs cater to students without prior healthcare experience. If you're new to nursing, exploring the best online BSN programs for non nurses can provide a flexible and accessible pathway to earn your Bachelor of Science in Nursing. These programs often balance theoretical knowledge with practical applications tailored for newcomers.

For those eager to advance quickly, accelerated nurse practitioner programs offer an expedited path to becoming a nurse practitioner. These intensive programs build on prior nursing education and prepare graduates for advanced clinical roles in immunology-related fields and beyond.

If you want an entry point into nursing, consider the easiest LPN programs to get into. Licensed Practical Nurse programs often require less time and experience to join, providing a valuable foundation in patient care and healthcare practices.

Choosing the right online program depends on your background, career goals, and timeline. The links above can help you compare options and find the best fit to support your journey in healthcare and immunology.

Best Scientists Citing Paul M. Kaye

Trending Scientists

Recently Published Articles